Ignite Creation Date:
2024-05-06 @ 8:23 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06364956
Status:
RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-03-06
Brief Title:
Phase IbII Trail of Neoadjuvant of Tislelizumab Combined With Palbociclib in Patients With Platinum-refractory Bladder Urothelial Carcinoma
Sponsor:
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University